Clinical Trial

Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to compare the efficacy of Glucophage plus Myo-Inositol versus Glucophage alone in glycemic control among patients with gestational diabetes mellitus (GDM). The study will assess whether the addition of Myo-Inositol improves glycemic control and reduces insulin requirements in GDM patients. Participants will be randomized into two groups: one receiving Myo-Inositol in combination with Glucophage and the other receiving Glucophage alone. The primary outcome will be glycemic control as assessed by fasting and postprandial glucose levels. Secondary outcomes include insulin requirement and gestational age at initiation of insulin therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-17.
Trial Details
NCT Number NCT06840613
Lead Sponsor University of Health Sciences Lahore
Conditions Gestational Diabetes Mellitus (GDM)
Enrollment 90 participants
Start Date 2025-03
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-02-25